1. Home
  2. BWB vs ZVRA Comparison

BWB vs ZVRA Comparison

Compare BWB & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgewater Bancshares Inc.

BWB

Bridgewater Bancshares Inc.

HOLD

Current Price

$21.44

Market Cap

571.1M

Sector

Finance

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$11.46

Market Cap

562.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWB
ZVRA
Founded
2005
2006
Country
United States
United States
Employees
355
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
571.1M
562.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
BWB
ZVRA
Price
$21.44
$11.46
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$21.67
$23.00
AVG Volume (30 Days)
175.9K
1.4M
Earning Date
04-21-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
159.21
EPS
N/A
0.74
Revenue
N/A
$106,470,000.00
Revenue This Year
$24.57
$37.27
Revenue Next Year
$12.35
$53.42
P/E Ratio
$12.97
$15.62
Revenue Growth
N/A
350.91
52 Week Low
$15.35
$7.16
52 Week High
$22.59
$15.04

Technical Indicators

Market Signals
Indicator
BWB
ZVRA
Relative Strength Index (RSI) 55.43 48.86
Support Level $20.79 $8.26
Resistance Level $21.91 $12.06
Average True Range (ATR) 0.60 0.57
MACD 0.00 0.14
Stochastic Oscillator 82.32 64.45

Price Performance

Historical Comparison
BWB
ZVRA

About BWB Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: